Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
Deep Genomics has raised $180.0M in total funding. The most recent round was Series C. The last funding was announced in July 2021.
Deep Genomics's investors include Khosla Ventures, True Ventures, Future Ventures, Creative Destruction Lab, Fidelity.
Deep Genomics is headquartered in Toronto, Canada.
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
Deep Genomics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deep Genomics — Funding & Investors." VCBacked, July 28, 2021, https://www.vcbacked.co/company/deep-genomics. Accessed August 14, 2026.
VCBacked. (2021). Deep Genomics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/deep-genomics
{{cite web |title=Deep Genomics — Funding & Investors |url=https://www.vcbacked.co/company/deep-genomics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated